ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,571 | -35.2% | 13,385 | -9.0% | 0.04% | -33.9% |
| Q2 2023 | $95,052 | +26.3% | 14,714 | +47.4% | 0.06% | +36.6% |
| Q1 2023 | $75,272 | -46.3% | 9,983 | -27.8% | 0.04% | -43.8% |
| Q4 2022 | $140,068 | +19.7% | 13,827 | +16.4% | 0.07% | +55.3% |
| Q3 2022 | $117,000 | -6.4% | 11,876 | +0.8% | 0.05% | +2.2% |
| Q2 2022 | $125,000 | +8.7% | 11,784 | 0.0% | 0.05% | -9.8% |
| Q1 2022 | $115,000 | -35.4% | 11,784 | -5.6% | 0.05% | -23.9% |
| Q4 2021 | $178,000 | +2.3% | 12,482 | +44.1% | 0.07% | -13.0% |
| Q3 2021 | $174,000 | -13.0% | 8,664 | -4.9% | 0.08% | -6.1% |
| Q2 2021 | $200,000 | – | 9,111 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |